Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06524232 · ClinicalTrials.gov registry record · NA
The STop UNhealthy Substance Use Now Trial
A NA study of Alcohol Use Disorder and Substance Use Disorders, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 144
- Enrollment target
- 3
- Study locations
NCT06524232: Recruiting NA study of Alcohol Use Disorder and Substance Use Disorders, sponsored by Ohio State University.
NCT06524232 is a NA study of Alcohol Use Disorder and Substance Use Disorders that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 144 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (56% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06524232, a NA study of Alcohol Use Disorder and Substance Use Disorders, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
- 3
- Study locations
Study Summary
The STop UNhealthy (STUN) Substance Use Now Trial (STUN II) is a multisite trial aiming to evaluate the comparative effectiveness of the following strategies for improving the implementation of screening and interventions for substance use disorders in primary care: practice facilitation (PF), PF plus a learning collaborative (LC), PF plus performance incentives (PI), and PF+LC+PI. We plan to enroll 144 clinic staff participants from 48 primary care practices
Primary Outcome
Number of people aged 18 and older who are screened for substance use disorder using a validated screening tool
Conditions Studied
Interventions
- OTHER Practice Facilitation (PF)
- OTHER Learning Collaborative (LC)
- OTHER Performance Incentives (PI)
Study Locations (3)
Ohio
- Bon Secours Mercy Health - Cincinnati
- The Ohio State University Wexner Medical Center - Columbus
- Ohio Association of Community Health Centers - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2024-09-16 |
| Est. Completion | 2027-09 |
| Phase | NA |
What NCT06524232 shows while recruiting
NCT06524232 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (56% lower).
The record links to 6 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which Practice Facilitation (PF) is the first listed.
NCT06524232 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06524232 about?
NCT06524232 is a clinical study titled "The STop UNhealthy Substance Use Now Trial". The STop UNhealthy (STUN) Substance Use Now Trial (STUN II) is a multisite trial aiming to evaluate the comparative effectiveness of the following strategies for improving the implementation of screening and interventions for substance use disorders in primary care: practice facilitation (PF), PF pl...
What is the current status of trial NCT06524232?
This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2024-09-16. Estimated completion is 2027-09.
What conditions does trial NCT06524232 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Substance Use Disorders, Substance Use, Substance Abuse, Drinking, Alcohol.
What interventions are being tested in trial NCT06524232?
The interventions under investigation include: Practice Facilitation (PF) (OTHER), Learning Collaborative (LC) (OTHER), Performance Incentives (PI) (OTHER).
Who is sponsoring clinical trial NCT06524232?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06524232 being conducted?
This trial has 3 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06524232's enrollment target sits among peer trials
144 68th of 184 higher than 116 of 184 other Alcohol Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
RECRUITING · NA
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
AAT for Alcohol Use Disorder in Veterans
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI